Loading Events

Go Back

event image

2nd Annual Global Summit on Hematologic Malignancies-Asia

April 18 - 20, 2019

OVERVIEW

Oncology Meeting Innovation’s (OMI’s) Global Summit on Hematologic Malignancies fosters discussion and debate on the evolution of treatment and features a focused approach towards individual patient populations through case-based discussions. New agents targeting BTK, PI3K delta, and BCL-2, as well as next-generation CD20 monoclonal antibodies, are changing the landscape and treatment paradigms for CLL. Similarly, recent data on drugs targeting CD38, SLAMF7, and HDAC, as well as novel approaches to proteasome inhibition, are advancing the continuum of treatment within multiple myeloma. Furthemore, advances in the understanding of the molecular biology and microenvironment have led to new approaches to treating lymphonma. Compelling data on the effects of novel strategies, such as CAR-T therapy, checkpoint inhibition, and next-generation antibody therapy, have led to an explosion of new information and agents in development for patients with hematologic malignancies. In response to these changes, the summit assembles translational researchers, clinical researchers, and key community oncologists to address the challenges of this rapidly evolving area of oncology.

Download the Brochure  

 

KEY TOPICS

  • Focus on acute and chronic leukemia, Hodgkin’s and non-Hodgkin’s lymphoma, and multiple myeloma.
  • Review the standards of care and discuss how new therapies can be incorporated into patient care.
  • Discuss personalized approaches to hematologic malignancies and the 2019 treatment landscape.
  • Debate advances in immunotherapy, including CAR-T therapy, bispecific antibodies, and inhibitors targeting checkpoint.

PROGRAM CHAIRS

2nd Annual Global Summit on Hematologic Malignancies-Asia

Kensei Tobinai, MD, PhD

Visiting Scientist National Cancer Center Hospital Tokyo, Japan

2nd Annual Global Summit on Hematologic Malignancies-Asia

John Pagel, MD, PhD

Chief of Hematologic Malignancies Swedish Cancer Institute Seattle, WA

ACCOMMODATIONS

Hilton Tokyo Bay

Hilton Tokyo Bay

Located on the eastern shore of Tokyo Bay, the hotel combines ocean views with ease of access to central Tokyo, just a 30-minute drive. Situated within Tokyo Disney Resort®, the hotel is a stroll away from the theme parks. We are also set 20 minutes from Tokyo Station and Marunouchi financial district. Amenities include flat-screen TVs, WiFi access, seating areas and great views.